BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Himmerich H, Treasure J. Psychopharmacological advances in eating disorders. Expert Rev Clin Pharmacol 2018;11:95-108. [PMID: 28933969 DOI: 10.1080/17512433.2018.1383895] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Brewerton TD. Mechanisms by which adverse childhood experiences, other traumas and PTSD influence the health and well-being of individuals with eating disorders throughout the life span. J Eat Disord 2022;10:162. [DOI: 10.1186/s40337-022-00696-6] [Reference Citation Analysis]
2 Macneil BA, Thib S. Psychiatric medication use by Canadian adults prior to entering an outpatient eating disorders program: Types and combinations of medications, predictors of being on a medication, and clinical considerations. Psychiatry Research 2022;317:114930. [DOI: 10.1016/j.psychres.2022.114930] [Reference Citation Analysis]
3 Coutinho E, Van Criekinge T, Hanford G, Nathan R, Maden M, Hill R. Music therapy interventions for eating disorders: Lack of robust evidence and recommendations for future research. British Journal of Music Therapy. [DOI: 10.1177/13594575221110193] [Reference Citation Analysis]
4 Márquez MC, Sánchez JM, Salazar AM, Martínez CV, Valderrama F, Rojas-gualdrón DF. Efficacy and safety of antipsychotics and antidepressants in the treatment of anorexia nervosa: a systematic review. Revista Colombiana de Psiquiatría (English ed ) 2022;51:227-235. [DOI: 10.1016/j.rcpeng.2022.08.007] [Reference Citation Analysis]
5 Shapiro MS. Special Psychosocial Issues in Diabetes Management: Diabetes Distress, Disordered Eating, and Depression. Primary Care: Clinics in Office Practice 2022;49:363-374. [DOI: 10.1016/j.pop.2021.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Brewerton TD, Perlman MM, Gavidia I, Suro G, Jahraus J. Headache, eating disorders, PTSD, and comorbidity: implications for assessment and treatment. Eat Weight Disord 2022. [PMID: 35604548 DOI: 10.1007/s40519-022-01414-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Muratore AF, Attia E. Psychopharmacologic Management of Eating Disorders. Curr Psychiatry Rep 2022. [PMID: 35576089 DOI: 10.1007/s11920-022-01340-5] [Reference Citation Analysis]
8 Lurati A. Depression and Obesity. The Journal for Nurse Practitioners 2022. [DOI: 10.1016/j.nurpra.2022.03.009] [Reference Citation Analysis]
9 Treasure J, Bektas S, Mutwalli H, Dhopatkar N, Himmerich H. Novel Approaches to Tackling Emotional Loss of Control of Eating Across the Weight Spectrum. Proc Nutr Soc 2022;:1-25. [PMID: 35260206 DOI: 10.1017/S0029665122000994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Galbally M, Himmerich H, Senaratne S, Fitzgerald P, Frost J, Woods N, Dickinson JE. Management of anorexia nervosa in pregnancy: a systematic and state-of-the-art review. The Lancet Psychiatry 2022. [DOI: 10.1016/s2215-0366(22)00031-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Avraham Y, Van Heukelom B, Zolotarev O, Magen I, Vorobiev L, Zwas DR. Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice. Physiol Behav 2022;:113738. [PMID: 35182554 DOI: 10.1016/j.physbeh.2022.113738] [Reference Citation Analysis]
12 Ohira K. Change of hypothalamic adult neurogenesis in mice by chronic treatment of fluoxetine. BMC Res Notes 2022;15:60. [PMID: 35172883 DOI: 10.1186/s13104-022-05954-z] [Reference Citation Analysis]
13 Borges K, Lewis YD, Bentley J, Himmerich H. Use of Antipsychotics in the Treatment of Eating Disorders. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_388] [Reference Citation Analysis]
14 Norris T, Dahl P, Jericho M, Crockford D. Identifying and Managing Eating Disorders in Persons Presenting for Addiction Treatment. Canadian Journal of Addiction 2021;12:6-16. [DOI: 10.1097/cxa.0000000000000129] [Reference Citation Analysis]
15 Marazziti D, Buccianelli B, Palermo S, Parra E, Arone A, Beatino MF, Massa L, Carpita B, Barberi FM, Mucci F. The Microbiota/Microbiome and the Gut-Brain Axis: How Much Do They Matter in Psychiatry? Life (Basel) 2021;11:760. [PMID: 34440503 DOI: 10.3390/life11080760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
16 Martinotti G, Chiappini S, Pettorruso M, Mosca A, Miuli A, Di Carlo F, D'Andrea G, Collevecchio R, Di Muzio I, Sensi SL, Di Giannantonio M. Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain Sci 2021;11:856. [PMID: 34199023 DOI: 10.3390/brainsci11070856] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
17 Voderholzer U, Haas V, Correll CU, Körner T. Medical management of eating disorders: an update. Curr Opin Psychiatry 2020;33:542-53. [PMID: 32925184 DOI: 10.1097/YCO.0000000000000653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
18 Himmerich H, Saedisomeolia A, Krügel U. Editorial: Extreme Eating Behaviours. Front Psychiatry 2020;11:639219. [PMID: 33569017 DOI: 10.3389/fpsyt.2020.639219] [Reference Citation Analysis]
19 Márquez MC, Sánchez JM, Salazar AM, Martínez CV, Valderrama F, Rojas-Gualdrón DF. Efficacy and Safety of Antipsychotics and Antidepressants in the Treatment of Anorexia Nervosa: a Systematic Review. Rev Colomb Psiquiatr (Engl Ed) 2021:S0034-7450(20)30121-9. [PMID: 33735059 DOI: 10.1016/j.rcp.2020.11.009] [Reference Citation Analysis]
20 Bergner L, Himmerich H, Kirkby KC, Steinberg H. Descriptions of Disordered Eating in German Psychiatric Textbooks, 1803-2017. Front Psychiatry 2020;11:504157. [PMID: 33519534 DOI: 10.3389/fpsyt.2020.504157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Himmerich H, Benkert O. Medikamente zur Behandlung von Essstörungen und Adipositas. Kompendium der Psychiatrischen Pharmakotherapie 2021. [DOI: 10.1007/978-3-662-61753-3_9] [Reference Citation Analysis]
22 Rocks T, West M, Hockey M, Aslam H, Lane M, Loughman A, Jacka FN, Ruusunen A. Possible use of fermented foods in rehabilitation of anorexia nervosa: the gut microbiota as a modulator. Prog Neuropsychopharmacol Biol Psychiatry 2021;107:110201. [PMID: 33307114 DOI: 10.1016/j.pnpbp.2020.110201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Sakae K, Suka M, Yanagisawa H. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study. J Clin Psychopharmacol 2020;40:599-606. [PMID: 33044355 DOI: 10.1097/JCP.0000000000001284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Khalsa SS, Moseman SE, Yeh HW, Upshaw V, Persac B, Breese E, Lapidus RC, Chappelle S, Paulus MP, Feinstein JS. Reduced Environmental Stimulation in Anorexia Nervosa: An Early-Phase Clinical Trial. Front Psychol 2020;11:567499. [PMID: 33123048 DOI: 10.3389/fpsyg.2020.567499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Patsalos O, Dalton B, Himmerich H. Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI: A Systematic Review and Meta-Analysis. Int J Mol Sci 2020;21:E6290. [PMID: 32878032 DOI: 10.3390/ijms21176290] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
26 Himmerich H, Kan C, Au K, Treasure J. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacol Ther 2021;217:107667. [PMID: 32858054 DOI: 10.1016/j.pharmthera.2020.107667] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
27 Wonderlich SA, Bulik CM, Schmidt U, Steiger H, Hoek HW. Severe and enduring anorexia nervosa: Update and observations about the current clinical reality. Int J Eat Disord 2020;53:1303-12. [PMID: 32359125 DOI: 10.1002/eat.23283] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
28 Patsalos O, Dalton B, Leppanen J, Ibrahim MAA, Himmerich H. Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis. Front Pharmacol 2020;11:481. [PMID: 32351392 DOI: 10.3389/fphar.2020.00481] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
29 Fumi M, Naab S, Voderholzer U. Diagnostik und Therapie von Essstörungen. gynäkologie + geburtshilfe 2020;25:27-34. [DOI: 10.1007/s15013-020-3019-8] [Reference Citation Analysis]
30 Treasure J, Willmott D, Ambwani S, Cardi V, Clark Bryan D, Rowlands K, Schmidt U. Cognitive Interpersonal Model for Anorexia Nervosa Revisited: The Perpetuating Factors that Contribute to the Development of the Severe and Enduring Illness. J Clin Med 2020;9:E630. [PMID: 32120847 DOI: 10.3390/jcm9030630] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 35.0] [Reference Citation Analysis]
31 Audet M, Stevens RC. Emerging structural biology of lipid G protein-coupled receptors. Protein Sci 2019;28:292-304. [PMID: 30239054 DOI: 10.1002/pro.3509] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
32 Birmingham CL. Comorbid Eating Disorders. Comorbidity 2020. [DOI: 10.1007/978-3-030-32545-9_5] [Reference Citation Analysis]
33 Borges K, Lewis YD, Bentley J, Himmerich H. Use of Antipsychotics in the Treatment of Eating Disorders. NeuroPsychopharmacotherapy 2020. [DOI: 10.1007/978-3-319-56015-1_388-1] [Reference Citation Analysis]
34 Treasure J, Eid L. Eating disorder animal model. Current Opinion in Psychiatry 2019;32:471-7. [DOI: 10.1097/yco.0000000000000550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Skånland SS, Cieślar-Pobuda A. Off-label uses of drugs for depression. Eur J Pharmacol 2019;865:172732. [PMID: 31622593 DOI: 10.1016/j.ejphar.2019.172732] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
36 Weibel S, Menard O, Ionita A, Boumendjel M, Cabelguen C, Kraemer C, Micoulaud-Franchi JA, Bioulac S, Perroud N, Sauvaget A, Carton L, Gachet M, Lopez R. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Encephale 2020;46:30-40. [PMID: 31610922 DOI: 10.1016/j.encep.2019.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
37 Dessain A, Bentley J, Treasure J, Schmidt U, Himmerich H. Patients’ and Carers’ Perspectives of Psychopharmacological Interventions Targeting Anorexia Nervosa Symptoms. Anorexia and Bulimia Nervosa 2019. [DOI: 10.5772/intechopen.86083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Naab S, Fumi M, Schlegl S, Voderholzer U. Stationäre Behandlung von Kindern und Jugendlichen mit Anorexia nervosa und Bulimia nervosa. Kindheit und Entwicklung 2019;28:230-41. [DOI: 10.1026/0942-5403/a000294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Pedrosa MAA, Nunes FT, Menescal LL, Rodrigues CHS, Appolinario JC. Aspectos gerais da avaliação e tratamento dos transtornos alimentares. Debates em Psiquiatria 2019;9:14-23. [DOI: 10.25118/2763-9037.2019.v9.50] [Reference Citation Analysis]
40 Moulton CD, Tharmaraja T, Hopkins CWP. Collaborative Care for Adults With Obesity and Depression. JAMA 2019;322:367-8. [PMID: 31334784 DOI: 10.1001/jama.2019.6774] [Reference Citation Analysis]
41 Scherma M, Collu R, Satta V, Giunti E, Fadda P. Animal Models of Eating Disorders. In: Kobeissy FH, editor. Psychiatric Disorders. New York: Springer; 2019. pp. 297-314. [DOI: 10.1007/978-1-4939-9554-7_17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
42 Volkoff H. Fish as models for understanding the vertebrate endocrine regulation of feeding and weight. Mol Cell Endocrinol 2019;497:110437. [PMID: 31054868 DOI: 10.1016/j.mce.2019.04.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
43 Nicoletti CF, Delfino HBP, Ferreira FC, Pinhel MADS, Nonino CB. Role of eating disorders-related polymorphisms in obesity pathophysiology. Rev Endocr Metab Disord 2019;20:115-25. [DOI: 10.1007/s11154-019-09489-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
44 Himmerich H, Bentley J, Lichtblau N, Brennan C, Au K. Facets of shared decision-making on drug treatment for adults with an eating disorder. Int Rev Psychiatry 2019;31:332-46. [PMID: 30870048 DOI: 10.1080/09540261.2019.1571995] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
45 Milano W, Capasso A. Psychopharmacological Options in the Multidisciplinary and Multidimensional Treatment of Eating Disorders. TONEUJ 2019;13:22-31. [DOI: 10.2174/1874205x01913010022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Blanchet C, Guillaume S, Bat-Pitault F, Carles ME, Clarke J, Dodin V, Duriez P, Gerardin P, Hanachi-Guidoum M, Iceta S, Leger J, Segrestin B, Stheneur C, Godart N. Medication in AN: A Multidisciplinary Overview of Meta-Analyses and Systematic Reviews. J Clin Med 2019;8:E278. [PMID: 30823566 DOI: 10.3390/jcm8020278] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
47 Himmerich H, Bentley J, Kan C, Treasure J. Genetic risk factors for eating disorders: an update and insights into pathophysiology. Ther Adv Psychopharmacol 2019;9:2045125318814734. [PMID: 30800283 DOI: 10.1177/2045125318814734] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 14.7] [Reference Citation Analysis]
48 Himmerich H, Benkert O. Medikamente zur Behandlung von Essstörungen und Adipositas. Kompendium der Psychiatrischen Pharmakotherapie 2019. [DOI: 10.1007/978-3-662-57334-1_9] [Reference Citation Analysis]
49 Mcelroy SL, Guerdjikova AI, Mori N, Romo-nava F. Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa. CNS Drugs 2019;33:31-46. [DOI: 10.1007/s40263-018-0594-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
50 Bargiacchi A, Clarke J, Paulsen A, Leger J. Refeeding in anorexia nervosa. Eur J Pediatr 2019;178:413-22. [PMID: 30483963 DOI: 10.1007/s00431-018-3295-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
51 Dalton B, Campbell IC, Chung R, Breen G, Schmidt U, Himmerich H. Inflammatory Markers in Anorexia Nervosa: An Exploratory Study. Nutrients 2018;10:E1573. [PMID: 30355978 DOI: 10.3390/nu10111573] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
52 Hübel C, Marzi SJ, Breen G, Bulik CM. Epigenetics in eating disorders: a systematic review. Mol Psychiatry 2019;24:901-15. [PMID: 30353170 DOI: 10.1038/s41380-018-0254-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
53 Himmerich H, Hotopf M, Shetty H, Schmidt U, Treasure J, Hayes RD, Stewart R, Chang CK. Psychiatric comorbidity as a risk factor for mortality in people with anorexia nervosa. Eur Arch Psychiatry Clin Neurosci 2019;269:351-9. [PMID: 30120534 DOI: 10.1007/s00406-018-0937-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
54 Peyron C, Rampon C, Petit JM, Luppi PH. Sub-regions of the dorsal raphé nucleus receive different inputs from the brainstem. Sleep Med 2018;49:53-63. [PMID: 30078667 DOI: 10.1016/j.sleep.2018.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
55 Mizusaki K, Gih D, Larosa C, Richmond R, Rienecke RD. Psychotropic usage by patients presenting to an academic eating disorders program. Eat Weight Disord 2018;23:769-74. [DOI: 10.1007/s40519-018-0520-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
56 Dalton B, Bartholdy S, Robinson L, Solmi M, Ibrahim MAA, Breen G, Schmidt U, Himmerich H. A meta-analysis of cytokine concentrations in eating disorders. J Psychiatr Res 2018;103:252-64. [PMID: 29906710 DOI: 10.1016/j.jpsychires.2018.06.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 23.0] [Reference Citation Analysis]
57 Fumi M, Naab S, Voderholzer U. Diagnostik und Therapie von Essstörungen. MMW - Fortschritte der Medizin 2018;160:62-70. [DOI: 10.1007/s15006-018-0011-5] [Reference Citation Analysis]